336 related articles for article (PubMed ID: 34518918)
21. Clinical course of Coronavirus Disease-19 in patients with haematological malignancies is characterized by a longer time to respiratory deterioration compared to non-haematological ones: results from a case-control study.
Oliva A; Curtolo A; Volpicelli L; Cancelli F; Borrazzo C; Cogliati Dezza F; Marcelli G; Gavaruzzi F; Di Bari S; Ricci P; Turriziani O; Mastroianni CM; Venditti M
Infection; 2022 Oct; 50(5):1373-1382. PubMed ID: 35781785
[TBL] [Abstract][Full Text] [Related]
22. Effect of age, comorbidity and remission status on outcome of COVID-19 in patients with hematological malignancies.
Borah P; Mirgh S; Sharma SK; Bansal S; Dixit A; Dolai TK; Lunkad S; Gupta N; Singh G; Jain A; Bansal D; Choudhary D; Khandelwal V; Doval D; Kumar M; Bhargava R; Chakrabarti A; Kalashetty M; Rauthan A; Kazi B; Mandal PK; Jeyaraman P; Naithani R;
Blood Cells Mol Dis; 2021 Mar; 87():102525. PubMed ID: 33338697
[TBL] [Abstract][Full Text] [Related]
23. Cycle threshold predicted mortality in a cohort of patients with hematologic malignancies infected with SARS-CoV-2.
Santarelli IM; Manzella DJ; Gallo Vaulet ML; Rodríguez Fermepín M; Crespo Y; Toledo Monaca S; Dobarro M; Fernández SI
Rev Argent Microbiol; 2023; 55(3):246-250. PubMed ID: 37208258
[TBL] [Abstract][Full Text] [Related]
24. Chronic comorbidities and clinical outcomes in patients with and without COVID-19: a large population-based study using national administrative healthcare open data of Mexico.
Martos-Benítez FD; Soler-Morejón CD; García-Del Barco D
Intern Emerg Med; 2021 Sep; 16(6):1507-1517. PubMed ID: 33411264
[TBL] [Abstract][Full Text] [Related]
25. Cardiovascular comorbidities as predictors for severe COVID-19 infection or death.
Phelps M; Christensen DM; Gerds T; Fosbøl E; Torp-Pedersen C; Schou M; Køber L; Kragholm K; Andersson C; Biering-Sørensen T; Christensen HC; Andersen MP; Gislason G
Eur Heart J Qual Care Clin Outcomes; 2021 Mar; 7(2):172-180. PubMed ID: 33107909
[TBL] [Abstract][Full Text] [Related]
26. Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study.
Yin SW; Zhou Z; Wang JL; Deng YF; Jing H; Qiu Y
Virol J; 2021 Jun; 18(1):126. PubMed ID: 34118952
[TBL] [Abstract][Full Text] [Related]
27. An Overview on COVID-19 and its Effect on Cardiovascular Diseases.
Hamadi A; Mahzari A; Hakami A; Hindawi S; Dobie G; Sayyed MI; Hamdi F; Nahari M; Jackson DE
Endocr Metab Immune Disord Drug Targets; 2021; 21(11):1949-1953. PubMed ID: 33371840
[TBL] [Abstract][Full Text] [Related]
28. Production and persistence of specific antibodies in COVID-19 patients with hematologic malignancies: role of rituximab.
Cattaneo C; Cancelli V; Imberti L; Dobbs K; Sottini A; Pagani C; Belotti A; Re A; Anastasia A; Quaresima V; Tucci A; Chiorini JA; Su HC; Cohen JI; Burbelo PD; Rossi G; Notarangelo LD
Blood Cancer J; 2021 Sep; 11(9):151. PubMed ID: 34521813
[TBL] [Abstract][Full Text] [Related]
29. COVID-19 in children with haematological malignancies.
Millen GC; Arnold R; Cazier JB; Curley H; Feltbower R; Gamble A; Glaser A; Grundy RG; Kirton L; Lee LYW; McCabe MG; Palles C; Phillips B; Stiller CA; Varnai C; Kearns P
Arch Dis Child; 2022 Feb; 107(2):186-188. PubMed ID: 34301621
[TBL] [Abstract][Full Text] [Related]
30. Clinical and virological characteristics of hospitalised COVID-19 patients in a German tertiary care centre during the first wave of the SARS-CoV-2 pandemic: a prospective observational study.
Thibeault C; Mühlemann B; Helbig ET; Mittermaier M; Lingscheid T; Tober-Lau P; Meyer-Arndt LA; Meiners L; Stubbemann P; Haenel SS; Bosquillon de Jarcy L; Lippert L; Pfeiffer M; Stegemann MS; Roehle R; Wiebach J; Hippenstiel S; Zoller T; Müller-Redetzky H; Uhrig A; Balzer F; von Kalle C; Suttorp N; Jones TC; Drosten C; Witzenrath M; Sander LE; ; Corman VM; Kurth F
Infection; 2021 Aug; 49(4):703-714. PubMed ID: 33890243
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive Characterization of COVID-19 Patients with Repeatedly Positive SARS-CoV-2 Tests Using a Large U.S. Electronic Health Record Database.
Dong X; Zhou Y; Shu XO; Bernstam EV; Stern R; Aronoff DM; Xu H; Lipworth L
Microbiol Spectr; 2021 Sep; 9(1):e0032721. PubMed ID: 34406805
[TBL] [Abstract][Full Text] [Related]
32. Viral kinetics of SARS-CoV-2 over the preclinical, clinical, and postclinical period.
Jang S; Rhee JY; Wi YM; Jung BK
Int J Infect Dis; 2021 Jan; 102():561-565. PubMed ID: 33160066
[TBL] [Abstract][Full Text] [Related]
33. SARS-CoV-2 viral load as a predictor for disease severity in outpatients and hospitalised patients with COVID-19: A prospective cohort study.
Knudtzen FC; Jensen TG; Lindvig SO; Rasmussen LD; Madsen LW; Hoegh SV; Bek-Thomsen M; Laursen CB; Nielsen SL; Johansen IS
PLoS One; 2021; 16(10):e0258421. PubMed ID: 34637459
[TBL] [Abstract][Full Text] [Related]
34. Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study.
Yang K; Sheng Y; Huang C; Jin Y; Xiong N; Jiang K; Lu H; Liu J; Yang J; Dong Y; Pan D; Shu C; Li J; Wei J; Huang Y; Peng L; Wu M; Zhang R; Wu B; Li Y; Cai L; Li G; Zhang T; Wu G
Lancet Oncol; 2020 Jul; 21(7):904-913. PubMed ID: 32479787
[TBL] [Abstract][Full Text] [Related]
35. Infections in haematologic neoplasms: autopsy findings.
Nosari A; Barberis M; Landonio G; Magnani P; Majno M; Oreste P; Sozzi P
Haematologica; 1991; 76(2):135-40. PubMed ID: 1937172
[TBL] [Abstract][Full Text] [Related]
36. Association between Prolonged Intermittent Renal Replacement Therapy and All-Cause Mortality in COVID-19 Patients Undergoing Invasive Mechanical Ventilation: A Retrospective Cohort Study.
Yang Y; Shi J; Ge S; Guo S; Xing X; Wang Y; Cheng A; Liu Q; Li J; Ning Y; He F; Xu G
Blood Purif; 2021; 50(4-5):481-488. PubMed ID: 33271549
[TBL] [Abstract][Full Text] [Related]
37. Factors associated with SARS-CoV-2 infection and outcome in patients with solid tumors or hematological malignancies: a single-center study.
Goudsmit A; Cubilier E; Meert AP; Aftimos P; Stathopoulos K; Spilleboudt C; Loizidou A
Support Care Cancer; 2021 Nov; 29(11):6271-6278. PubMed ID: 33851236
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of SARS-CoV-2 in Tears of Patients with Moderate to Severe COVID-19.
Arora R; Goel R; Kumar S; Chhabra M; Saxena S; Manchanda V; Pumma P
Ophthalmology; 2021 Apr; 128(4):494-503. PubMed ID: 32882309
[TBL] [Abstract][Full Text] [Related]
39. Persistent SARS-CoV-2 RNA Shedding Without Evidence of Infectiousness: A Cohort Study of Individuals With COVID-19.
Owusu D; Pomeroy MA; Lewis NM; Wadhwa A; Yousaf AR; Whitaker B; Dietrich E; Hall AJ; Chu V; Thornburg N; Christensen K; Kiphibane T; Willardson S; Westergaard R; Dasu T; Pray IW; Bhattacharyya S; Dunn A; Tate JE; Kirking HL; Matanock A;
J Infect Dis; 2021 Oct; 224(8):1362-1371. PubMed ID: 33649773
[TBL] [Abstract][Full Text] [Related]
40. An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner.
Agrawal H; Das N; Nathani S; Saha S; Saini S; Kakar SS; Roy P
Stem Cell Rev Rep; 2021 Feb; 17(1):94-112. PubMed ID: 33029768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
